Author

M.-S. Song

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:benchmarking· 1

Frequent Co-Authors

H. Kim· 2 shared J. H. Jeong· 2 shared Y. H. Baek· 2 shared Y. K. Choi· 2 shared A. Ensser· 1 shared B. Kim· 1 shared D. B. Lee· 1 shared D. H. Kang· 1 shared

Activity by Year

2022-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

H. Kim

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivPreprintSep 27, 2022

SARS-CoV-2 variants show temperature-dependent enhanced polymerase activity in the upper respiratory tract and high transmissibility

S.-M. Kim, E.-H. Kim, M. A. B. Casel…·Y. K. Choi

This study shows SARS-CoV-2 variants with P323L or P323L/G671S mutations in NSP12 have enhanced polymerase activity at 33°C and higher transmissibility in ferrets.

DOI 10.1101/2022.09.27.509689

mouseexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivJun 27, 2022

Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice

J. H. Jeong, S. Chokkakula, S. C. Min…·M.-S. Song

This paper evaluates combination antiviral therapies in SARS-CoV-2 infected mice, finding that nirmatrelvir and molnupiravir together significantly improve survival compared to monotherapies.

DOI 10.1016/j.antiviral.2022.105430

mouseexperimental assay

𝕏 PostBluesky

BioengineeringbioRxivPreprintFeb 18, 2022

Mosaic receptor-binding domain nanoparticles induce protective immunity against SARS-CoV-2 challenges

D. B. Lee, H. Kim, J. H. Jeong…·K. H. Kim

This paper develops a mosaic nanoparticle vaccine, 6RBD-np, that induces full protection against SARS-CoV-2 wild type and Delta variants in mice.

DOI 10.1101/2022.02.18.480994

mouseexperimental assay

𝕏 PostBluesky